VARIATIONS IN THE PREVALENCE OF RESPIRATORY SYMPTOMS, SELF-REPORTED ASTHMA ATTACKS, AND USE OF ASTHMA MEDICATION IN THE EUROPEAN-COMMUNITY RESPIRATORY HEALTH SURVEY (ECRHS)
P. Burney et al., VARIATIONS IN THE PREVALENCE OF RESPIRATORY SYMPTOMS, SELF-REPORTED ASTHMA ATTACKS, AND USE OF ASTHMA MEDICATION IN THE EUROPEAN-COMMUNITY RESPIRATORY HEALTH SURVEY (ECRHS), The European respiratory journal, 9(4), 1996, pp. 687-695
Asthma is a common chronic disorder which may be increasing in prevale
nce. However, little is known of its distribution and determinants. Th
e European Community Respiratory Health Survey (ECRHS) is a multicentr
e survey of the prevalence, determinants and management of asthma This
paper presents a descriptive account of the variation in self-reporte
d attacks of asthma and asthma symptoms across Europe, and in part ful
fils the first aim of the study. A screening questionnaire, including
seven questions relating to the 12 month prevalence of symptoms of ast
hma, was distributed to representative samples of 20-44 year old men a
nd women in 48 centres, predominantly in Western Europe. The median re
sponse rate to the questionnaire was 75% but, after removing from the
denominator those who were the wrong age, were known to have moved out
of the area, or had died, it was 78% (range 54-100). The prevalence o
f all symptoms varied widely. Although these were generally lower in n
orthern, central and southern Europe and higher in the British Isles,
New Zealand, Australia and the United States, there were wide variatio
ns even within some countries. Centres with a high prevalence of self-
reported attacks of asthma also reported high prevalences of nasal all
ergies and of waking at night with breathlessness. The use of asthma m
edication was more common where wheeze and asthma attacks were more fr
equent. In most centres in The Netherlands, Sweden, New Zealand and th
e United Kingdom over 80% of those with a diagnosis of asthma were cur
rently using asthma medication. In Italy, France and Spain the rate wa
s generally less than 70%. These data are the best evidence to date th
at geographical differences in asthma prevalence exist, are substantia
l and are not an artefact of the use of noncomparable methods.